Scarica l'app Stockscreener
271.39
0.58%
1.56
Precedente Chiudi:
$269.83
Aprire:
$265.4
Volume 24 ore:
1.01M
Relative Volume:
0.67
Capitalizzazione di mercato:
$38.87B
Reddito:
$2.50B
Utile/perdita netta:
$-226.32M
Rapporto P/E:
-165.36
EPS:
-1.6412
Flusso di cassa netto:
$71.51M
1 W Prestazione:
+0.53%
1M Prestazione:
+19.85%
6M Prestazione:
+17.36%
1 anno Prestazione:
+89.28%
Intervallo 1D:
$262.00
$272.31
Intervallo di 1 settimana:
$261.63
$282.00
Portata 52W:
$131.81
$288.04
Natera Inc Stock (NTRA) Company Profile
Nome
Natera Inc
Settore
Industria
Telefono
650-249-9090
Indirizzo
13011 MCCALLEN PASS, AUSTIN, CA
Compare NTRA vs TMO, DHR, IDXX, A
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
NTRA
Natera Inc
|
271.39 | 38.64B | 2.50B | -226.32M | 71.51M | -1.6412 |
TMO
Thermo Fisher Scientific Inc
|
532.48 | 201.86B | 45.20B | 6.87B | 6.75B | 18.19 |
DHR
Danaher Corp
|
203.83 | 145.10B | 24.78B | 3.68B | 5.29B | 5.1743 |
IDXX
Idexx Laboratories Inc
|
567.44 | 45.44B | 4.45B | 1.10B | 1.06B | 13.59 |
A
Agilent Technologies Inc
|
131.46 | 38.44B | 7.23B | 1.41B | 1.09B | 4.979 |
Natera Inc Stock (NTRA) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-04-14 | Iniziato | William Blair | Outperform |
| 2026-01-07 | Iniziato | Citigroup | Buy |
| 2025-12-02 | Ripresa | Morgan Stanley | Overweight |
| 2025-10-27 | Aggiornamento | BNP Paribas Exane | Underperform → Neutral |
| 2025-09-22 | Ripresa | Wells Fargo | Equal Weight |
| 2025-03-13 | Iniziato | RBC Capital Mkts | Outperform |
| 2025-01-23 | Iniziato | Barclays | Overweight |
| 2024-06-03 | Ripresa | Jefferies | Buy |
| 2024-04-08 | Ripresa | Craig Hallum | Buy |
| 2024-02-20 | Downgrade | Raymond James | Strong Buy → Outperform |
| 2023-12-29 | Reiterato | BTIG Research | Buy |
| 2023-12-14 | Iniziato | Guggenheim | Buy |
| 2023-12-13 | Iniziato | Wolfe Research | Outperform |
| 2023-11-13 | Aggiornamento | Raymond James | Outperform → Strong Buy |
| 2023-09-28 | Iniziato | Bernstein | Mkt Perform |
| 2023-07-05 | Ripresa | JP Morgan | Overweight |
| 2023-05-05 | Iniziato | UBS | Buy |
| 2023-01-18 | Aggiornamento | Raymond James | Mkt Perform → Outperform |
| 2022-08-25 | Iniziato | Credit Suisse | Outperform |
| 2022-04-25 | Iniziato | Stephens | Overweight |
| 2022-03-08 | Iniziato | Goldman | Buy |
| 2022-01-06 | Ripresa | Piper Sandler | Overweight |
| 2021-10-15 | Ripresa | Cowen | Outperform |
| 2021-06-15 | Iniziato | Raymond James | Mkt Perform |
| 2021-05-25 | Iniziato | Wells Fargo | Overweight |
| 2021-01-28 | Iniziato | Truist | Buy |
| 2020-10-08 | Iniziato | BTIG Research | Buy |
| 2020-09-28 | Iniziato | Morgan Stanley | Overweight |
| 2020-09-17 | Iniziato | SVB Leerink | Outperform |
| 2020-06-10 | Ripresa | Piper Sandler | Overweight |
| 2020-05-07 | Aggiornamento | JP Morgan | Neutral → Overweight |
| 2018-10-05 | Iniziato | JP Morgan | Neutral |
| 2018-07-05 | Reiterato | Piper Jaffray | Overweight |
| 2017-08-07 | Reiterato | Morgan Stanley | Overweight |
| 2016-11-10 | Reiterato | The Benchmark Company | Buy |
| 2016-05-23 | Reiterato | The Benchmark Company | Buy |
| 2016-05-11 | Reiterato | The Benchmark Company | Buy |
| 2016-04-19 | Iniziato | The Benchmark Company | Buy |
| 2015-09-28 | Aggiornamento | Wedbush | Neutral → Outperform |
| 2015-08-14 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2015-08-04 | Iniziato | Robert W. Baird | Outperform |
| 2015-07-27 | Iniziato | Morgan Stanley | Equal-Weight |
| 2015-07-27 | Iniziato | Piper Jaffray | Overweight |
| 2015-07-27 | Iniziato | Wedbush | Neutral |
Mostra tutto
Natera Inc Borsa (NTRA) Ultime notizie
Insider Sell: Rowan Chapman Sells Shares of Natera Inc (NTRA) - GuruFocus
Natera co-founder Sheena Jonathan sells $410,825 in NTRA stock - Investing.com UK
Natera director Rowan Chapman sells $37,100 in company stock - Investing.com
Natera (NASDAQ: NTRA) co-founder’s trusts sell 1,500 shares - Stock Titan
Natera (NASDAQ: NTRA) director Chapman sells 135 shares in 10b5-1 trade - Stock Titan
Natera co-founder, Director Sheena Jonathan disposes of 1,500 common shares worth $410,322.91 - Bitget
Finalized MolDx LCD Includes Expanded Coverage for Natera’s Prospera™ Portfolio - Business Wire
The Bull Case For Natera (NTRA) Could Change Following New Signatera JAMA Oncology Evidence On MRD-Guided Chemotherapy - simplywall.st
Q1 Earnings Highs And Lows: Natera (NASDAQ:NTRA) Vs The Rest Of The Biotechnology Stocks - Yahoo Finance
Billionaire Stanley Druckenmiller's Top Holding Isn't Nvidia. Instead, It's This Under-the-Radar Stock That Wall Street Loves. - The Motley Fool
What's Driving Natera's Recent Stock Action, and Why Are Insiders Selling - Kavout | AI
Natera co-founder Sheena Jonathan sells $836,898 in stock - Investing.com UK
Natera co-founder Sheena Jonathan sells $836,898 in stock By Investing.com - Investing.com India
Form 4 Natera Inc For: 15 July By Investing.com - Investing.com Nigeria
Natera (NTRA) co-founder sells 3,150 shares under Rule 10b5-1 plan - Stock Titan
Rowan Emma Chapman (NASDAQ: NTRA) files Form 144 to sell shares - Stock Titan
Form 144 Natera For: 15 July By Investing.com - Investing.com Canada
NTRA (NASDAQ: NTRA) holder plans sale of 1,500 common shares - Stock Titan
NATERA INC : TD COWEN RAISES TARGET PRICE TO $325 FROM $280 - Moomoo
NTRA Maintained by Canaccord Genuity -- Price Target Raised to $330 - GuruFocus
Enterprise value to EBITDA forward of Natera, Inc. – BX:NTRA - TradingView
Form 144 Natera For: 13 July By Investing.com - Investing.com Nigeria
[144] Natera, Inc. SEC Filing - Stock Titan
Enterprise value to EBITDA forward of Natera, Inc. – XETR:45E - TradingView
Did EU Class C Status for Signatera Reshape Natera’s (NTRA) Long-Term Diagnostics Strategy? - Yahoo Finance
What's Driving Natera's Recent Stock Action and Insider Selling - Kavout | AI
Is Natera (NTRA) Fully Valued As Signatera Wins EU IVDR Certification? - simplywall.st
Natera (NTRA) Secures EU Certification, Is The Upside Already Priced In? - Yahoo Finance
Why Natera (NTRA) Stock Is Down Today - Quiver Quantitative
Natera (NTRA) Signatera Data Shows Who Benefits From Chemotherapy After CRC Surgery - Yahoo Finance
NTRA's Signatera Gains EU IVDR Certification for Multiple Cancers - Yahoo Finance
Natera (NTRA) Stock Still Looks Expensive After A Very Large Run - Yahoo Finance
NTRA Maintained by Morgan Stanley -- Price Target Raised to $310 - GuruFocus
Morgan Stanley Maintains Natera(NTRA.US) With Buy Rating, Raises Target Price to $310 - Moomoo
Natera, Inc. Stock 12‑Month Price Target Raised to $272.19, Implies 1% Downside - TradingView
Natera Announces IVDR Certification for Signatera™ Across Multiple Cancers - 01net
How New Signatera Colorectal Data and Trial Deals Could Shape Natera’s (NTRA) Long-Term Narrative - simplywall.st
Natera’s Signatera receives EU IVDR certification for MRD testing By Investing.com - Investing.com Nigeria
Natera’s Signatera receives EU IVDR certification for MRD testing - Investing.com
Natera Receives EU IVDR Certification for Signatera - Moomoo
Natera (NTRA) Achieves Significant Milestone with Signatera IVDR Certification - GuruFocus
Natera's Insider Selling Spree: A Red Flag Amidst Robust Growth - Kavout | AI
NATERA INC : JEFFERIES RAISES TARGET PRICE TO $325 FROM $275 - Moomoo
Natera executive chairman Matthew Rabinowitz sells $280,000 in shares By Investing.com - Investing.com Nigeria
Natera executive chairman Matthew Rabinowitz sells $280,000 in shares - Investing.com
(NTRA) Volatility Zones as Tactical Triggers - Stock Traders Daily
Form 4 Natera Inc For: 8 July By Investing.com - Investing.com Nigeria
Natera (NTRA) executive chair’s spouse sells 1,000 shares in pre‑planned trade - Stock Titan
Form 4 Natera Inc For: 6 July By Investing.com - Investing.com India
Natera president Solomon Moshkevich sells $818,710 in stock - Investing.com UK
Natera chief legal officer Daniel Rabinowitz sells $4.57m stock - Investing.com
Natera Inc Azioni (NTRA) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
3.41%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):